1-2 of 2
Yanmin Chen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice

Xin Chen, Yanmin Chen, Rong Liang, Lanxin Xiang, Jingwen Li, Yuankui Zhu, Huixia He, Le Huang, Dianbao Zuo, Weihang Li, Xinjun Liang, Shuang Dong, Sheng Hu, Mitchell Ho, Mingqian Feng
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2022) 21 (1): 149–158.
https://doi.org/10.1158/1535-7163.MCT-20-1025
Published: 07 January 2022
View article titled, Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice
Open the PDF for Combination Therapy of Hepatocellular Carcinoma by GPC3-Targeted Bispecific Antibody and Irinotecan is Potent in Suppressing Tumor Growth in Mice in another window
Journal Articles

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia

Carl L. Manthey, Dana L. Johnson, Carl R. Illig, Robert W. Tuman, Zhao Zhou, Judith F. Baker, Margery A. Chaikin, Robert R. Donatelli, Carol F. Franks, Lee Zeng, Carl Crysler, Yanmin Chen, Edward J. Yurkow, Lisa Boczon, Sanath K. Meegalla, Kenneth J. Wilson, Mark J. Wall, Jinsheng Chen, Shelley K. Ballentine, Heidi Ott, Christian Baumann, Danielle Lawrence, Bruce E. Tomczuk, Christopher J. Molloy
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 3151–3161.
https://doi.org/10.1158/1535-7163.MCT-09-0255
Published: 10 November 2009
View article titled, JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia
Open the PDF for JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia in another window
Includes: Supplementary data